Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
Timely screening and accurate detection through precision diagnostics, targeted therapy, risk reducing surgeries, and comprehensive multimodality treatment options have resulted in improving survival rates and quality of life in cancer patients in India
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
Subscribe To Our Newsletter & Stay Updated